Experiments for taxon Chrysanthemum boreale (ASTERACEAE)

Experiments (110 results)

Filters
Worktypes (18)
62
21
15
14
13
11
8
8
6
5
4
4
4
3
2
2
1
1
No match
Pharmacology (15)
40
15
9
5
3
2
1
1
1
1
1
1
1
1
28
No match
Compounds (22)
15
11
11
11
7
7
6
4
3
2
2
2
2
2
1
1
1
1
1
1
1
21
No match
Organisms (19)
36
16
13
10
10
4
3
3
3
2
2
1
1
1
1
1
1
1
1
No match
110 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
662452
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
662461
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
661112
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
APIGENIN
303922
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-ACETOXY-2-METHOXY-10-HYDROXY:
662472
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
303934
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INDUCTION
Chrysanthemum boreale (ASTERACEAE)
BORENOLIDE
381830
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
TULIPINOLIDE
273565
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INHIBITION
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
726792
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
273562
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INHIBITION
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
738461
VOUCHER SPECIMEN REPORTED FOR
Chrysanthemum boreale (ASTERACEAE)
604474
MEDICINAL FOLKLORE REPORTED FOR
ANALGESIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
662458
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
662469
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
273566
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INHIBITION
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
303919
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-ACETOXY-2-METHOXY-10-HYDROXY:
726791
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIADHESION EFFECT
Chrysanthemum boreale (ASTERACEAE)
661106
PHARMACOLOGY OF EXTRACT - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
662475
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
381831
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
COSTUNOLIDE
662447
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
661117
PHARMACOLOGY OF COMPOUND - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
LINARIN
662464
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
381829
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
TULIPINOLIDE
662460
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
661107
PHARMACOLOGY OF EXTRACT - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
600696
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
738462
PHARMACOLOGY OF EXTRACT - IN VITRO
ANGIOGENESIS INHIBITION
Chrysanthemum boreale (ASTERACEAE)
661113
PHARMACOLOGY OF COMPOUND - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
APIGENIN
662471
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
273561
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INHIBITION
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
273557
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Chrysanthemum boreale (ASTERACEAE)
GUAIA-4(15)-10(13)-DIEN-12-6-OLIDE,8-O-ACETYL-3-10-DIHYDROXY:
600715
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
1257815
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
PONTICA EPOXIDE
662455
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
636209
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
661111
PHARMACOLOGY OF COMPOUND - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
ACACETIN
1270756
ISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
MATRICARIA ESTER,DEHYDRO:TRIDDECA-1-3-5-TRIENE-7-9-11-TRIYNE
662466
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
381827
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
TULIPINOLIDE
662448
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
303923
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-ACETOXY-2-METHOXY-10-HYDROXY:
662459
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
273560
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
303926
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-10-DIACETOXY-2-METHOXY:
662477
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
662444
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
303920
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-ACETOXY-2-METHOXY-10-HYDROXY:
662470
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
273558
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INHIBITION
Chrysanthemum boreale (ASTERACEAE)
GUAIA-4(15)-10(13)-DIEN-12-6-OLIDE,8-O-ACETYL-3-10-DIHYDROXY:
346308
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Chrysanthemum boreale (ASTERACEAE)
662474
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
346307
VOUCHER SPECIMEN REPORTED FOR
Chrysanthemum boreale (ASTERACEAE)
662463
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
600695
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
661114
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
LUTEOLIN
303931
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-10-DIACETOXY-2-METHOXY:
381834
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
COSTUNOLIDE
303929
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-10-DIACETOXY-2-METHOXY:
604475
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
661108
PHARMACOLOGY OF EXTRACT - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
381826
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
TULIPINOLIDE
303927
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-10-DIACETOXY-2-METHOXY:
303932
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INDUCTION
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-10-DIACETOXY-2-METHOXY:
662456
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
1270755
ISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
ARTEMISIA-TRANS-SPIROKETALENOETHER POLYNE
273564
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
661110
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
ACACETIN
604472
MEDICINAL FOLKLORE REPORTED FOR
ANTIPYRETIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
303924
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-ACETOXY-2-METHOXY-10-HYDROXY:
1112090
ISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
QUERCETIN GLYCOSIDEACACIINCYNAROSIDE
662454
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
661109
PHARMACOLOGY OF EXTRACT - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
661115
PHARMACOLOGY OF COMPOUND - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
LUTEOLIN
662443
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
662445
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
624826
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Chrysanthemum boreale (ASTERACEAE)
LUTEOLIN
273559
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
677662
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
381833
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
COSTUNOLIDE
662451
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
662467
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
303930
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-10-DIACETOXY-2-METHOXY:
303928
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-10-DIACETOXY-2-METHOXY:
600694
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
636208
ISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
273563
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
591003
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
661116
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
LINARIN
303933
ISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
BORENOLIDE
661105
PHARMACOLOGY OF EXTRACT - IN VITRO
ALDOSE REDUCTASE INHIBITION
Chrysanthemum boreale (ASTERACEAE)
662450
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
662449
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
662453
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
303921
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-ACETOXY-2-METHOXY-10-HYDROXY:
636210
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOTENSIVE ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
662442
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
662468
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
381832
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
COSTUNOLIDE
662476
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
604473
MEDICINAL FOLKLORE REPORTED FOR
ANTIVERTIGO EFFECT
Chrysanthemum boreale (ASTERACEAE)
381825
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Chrysanthemum boreale (ASTERACEAE)
TULIPINOLIDE
662457
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN A
303925
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INDUCTION
Chrysanthemum boreale (ASTERACEAE)
GUAIA-3-11(13)-DIEN-6-12-OLIDE,8-ACETOXY-2-METHOXY-10-HYDROXY:
662446
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B
381828
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
TULIPINOLIDE
662473
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,TIGLOYL:
662465
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL:
726790
VOUCHER SPECIMEN REPORTED FOR
Chrysanthemum boreale (ASTERACEAE)
662462
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Chrysanthemum boreale (ASTERACEAE)
CUMAMBRIN B,ANGELOYL: